The therapeutic effect of FTY720 on lupus nephritis in autoimmune MRL/lpr mice

被引：0
|
作者：
Sugahara, K [1 ]
Kataoka, H [1 ]
Ohtsuki, M [1 ]
Hoshino, Y [1 ]
Chiba, K [1 ]
机构：
[1] Mitsubishi Pharma Corp, Res Lab 3, Pharmaceut Res Unit, Div Res & Dev, Yokohama, Kanagawa, Japan
来源：
IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION | 2004年
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Sphingosine 1-phosphate receptor agonist, FTY720 at oral doses of 0.03 to 1 mg/kg exhibited the prophylactic and therapeutic effect on lupus nephritis spontaneously developed in MRL/lpr mice. The therapeutical administration of FTY720 resulted in a decrease in the number of T cells, especially CD4(+) T cells, infiltrated into kidney as well as reduction of lymphocytes in blood. Moreover, the elevation of Th1 cytokine/chemokine mRNA expression was decreased in kidneys of FTY720-treated group. These results suggest that FTY720 decreases autoreactive Th1 cell infiltration into kidneys by reduction of circulating lymphocytes in blood, and thereby shows a marked therapeutic effect on progressing lupus nephritis of MRL/lpr mice.
引用
下载
收藏
页码：271 / 274
页数：4
相关论文
共 50 条
  • [31] FK506 - THERAPEUTIC EFFECTS ON LUPUS DERMATOSES IN AUTOIMMUNE-PRONE MRL/MP-LPR/LPR MICE
    FURUKAWA, F
    IMAMURA, S
    TAKIGAWA, M
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (06) : 558 - 563
  • [32] ABROGATION OF MRL LPR LUPUS NEPHRITIS BY DIETARY FLAXSEED
    HALL, AV
    PARBTANI, A
    CLARK, WF
    SPANNER, E
    KEENEY, M
    IAN, CY
    PHILBRICK, DJ
    HOLUB, BJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (02) : 326 - 332
  • [33] Lack of FGF-1 overexpression during autoimmune nephritis in the kidneys of MRL lpr lpr mice
    Madiai, F
    Hackshaw, KV
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1999, 103 (01) : 37 - 44
  • [34] Relapse of Experimental Autoimmune Encephalomyelitis after Discontinuation of FTY720 (Fingolimod) Treatment, but Not after Combination of FTY720 and Pathogenic Autoantigen
    Yoshida, Yuya
    Tsuji, Takumi
    Fujta, Tetsuro
    Kohno, Takeyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (06) : 933 - 937
  • [35] Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis
    Fan, XH
    Wuthrich, RP
    INFLAMMATION, 1997, 21 (01) : 105 - 112
  • [36] Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720
    Maki, T
    Gottschalk, R
    Ogawa, N
    Monaco, AP
    TRANSPLANTATION, 2005, 79 (09) : 1051 - 1055
  • [37] Therapeutic Effects of Triptolide on Lupus-prone MRL/lpr Mice
    Huang, Xueqin
    Wen, Chengping
    Wei, Hua
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (05) : 681 - 688
  • [38] The Effect of FTY720 in an Animal Model of MS
    Pachner, Andrew R.
    Apte, Priyanka
    Brady, Jennifer
    Li, Libin
    ANNALS OF NEUROLOGY, 2009, 66 : S33 - S34
  • [39] Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice
    Sadanaga, Atsushi
    Nakashima, Hitoshi
    Akahoshi, Mitsuteru
    Masutani, Kohsuke
    Miyake, Katsuhisa
    Igawa, Takashi
    Sugiyama, Naonobu
    Niiro, Hiroaki
    Harada, Mine
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1618 - 1628
  • [40] STAT3 Inhibition Delays the Onset of Lupus Nephritis in MRL/Lpr Mice
    Edwards, Linsday
    Kyttaris, Vasileios C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S289 - S289
12345